Deferred Tax Assets, Valuation Allowance of Microbot Medical Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Microbot Medical Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • Microbot Medical Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $118,374,000, a 2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Microbot Medical Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $118,374,000 +$2,360,000 +2% 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q4 2023 $116,014,000 +$2,559,000 +2.3% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q4 2022 $113,455,000 +$2,919,000 +2.6% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q4 2021 $110,536,000 +$2,962,000 +2.8% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $107,574,000 -$8,131,000 -7% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $115,705,000 +$1,661,000 +1.5% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $114,044,000 +$1,664,000 +1.5% 31 Dec 2018 10-K 14 Apr 2020 2019 FY
Q2 2018 $103,313,000 -$8,427,000 -7.5% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $102,916,000 -$12,841,000 -11% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $112,380,000 -$7,883,000 -6.6% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 $487,017,000 +$485,950,000 +45544% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 $111,740,000 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $115,757,000 31 Mar 2017 10-Q 15 May 2018 2018 Q1
Q4 2016 $120,263,000 +$119,791,020 +25381% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $1,067,000 +$328,000 +44% 30 Sep 2016 8-K 06 Feb 2017
Q4 2015 $471,980 -$128,020 -21% 31 Dec 2015 10-K 21 Mar 2017 2016 FY
Q3 2015 $739,000 30 Sep 2015 8-K 06 Feb 2017
Q4 2014 $600,000 -$127,715,000 -100% 31 Dec 2014 8-K 06 Feb 2017
Q4 2013 $128,315,000 +$10,270,000 +8.7% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q4 2012 $118,045,000 +$864,000 +0.74% 31 Dec 2012 10-K 13 Mar 2014 2013 FY
Q4 2011 $117,181,000 31 Dec 2011 10-K 21 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.